The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine.
Jan Simon ScharrenbergAyla YagdiranJulia BrinkmannMaik BruneJan SieweNorma JungEsther MahabirPublished in: Journal of orthopaedic surgery and research (2019)
ClinicalTrials.gov, NCT02554227, posted Sept. 18, 2015, and updated Aug. 13, 2019.
Keyphrases